These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24074765)

  • 1. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients.
    van der Ploeg AP; van Akkooi AC; Haydu LE; Scolyer RA; Murali R; Verhoef C; Thompson JF; Eggermont AM
    Eur J Cancer; 2014 Jan; 50(1):111-20. PubMed ID: 24074765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
    Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
    Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
    van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
    Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
    Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
    Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of a scoring system to predict nonsentinel-node metastasis and prognosis in melanoma patients.
    Cadili A; Dabbs K; Scolyer RA; Brown PT; Thompson JF
    J Am Coll Surg; 2010 Oct; 211(4):522-5. PubMed ID: 20729103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
    van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
    Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.
    Fink AM; Weihsengruber F; Duschek N; Schierl M; Wondratsch H; Jurecka W; Rappersberger K; Steiner A
    Melanoma Res; 2011 Apr; 21(2):139-43. PubMed ID: 21317817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
    Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
    J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of melanoma micrometastases in sentinel nodes - the cons.
    de Wilt JH; van Akkooi AC; Verhoef C; Eggermont AM
    Surg Oncol; 2008 Sep; 17(3):175-81. PubMed ID: 18617395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node for malignant melanoma: An observational study of a consecutive single centre experience.
    Belgrano V; Katsarelias D; Mattsson J; Olofsson Bagge R
    Eur J Surg Oncol; 2019 Feb; 45(2):225-230. PubMed ID: 30391091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection and significance of melanoma micrometastases in sentinel nodes.
    Scolyer RA; Murali R; Satzger I; Thompson JF
    Surg Oncol; 2008 Sep; 17(3):165-74. PubMed ID: 18639451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model.
    Wiener M; Acland KM; Shaw HM; Soong SJ; Lin HY; Chen DT; Scolyer RA; Winstanley JB; Thompson JF
    Ann Surg Oncol; 2010 Aug; 17(8):1995-2005. PubMed ID: 20490699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
    Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
    Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.